As of Oct 09
| +0.73 / +0.78%|
The 5 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 116.00, with a high estimate of 125.00 and a low estimate of 107.00. The median estimate represents a +22.86% increase from the last price of 94.42.
The current consensus among 6 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.